Dabs for Pain Relief: Evidence, Risks, Dosing

Dabs for pain relief: the short answer

Some people report that dabs reduce pain. Evidence from trials is limited. Most pain studies use cannabis extracts or pills, not dabs. Dabs are concentrates with THC levels from 50% to 90%. The FDA has not approved cannabis flower or dabs for pain. Clinicians do not rank dabs as first-line treatment.

dabs for pain relief

What dabs are

Dabs are cannabis concentrates. A person inhales vapor from a heated surface. A single dab can contain 20 mg to 100 mg of THC. A joint may contain 10 mg to 20 mg. THC dose per dab varies by product and batch.

related article

What the evidence says

Reviews of cannabinoids for chronic pain report modest pain reduction in some trials. Most trials use nabiximols, an oral spray with THC and CBD. Trials of smoked cannabis show mixed results. Trials of dabs are scarce. A 2017 National Academies report found evidence for cannabis in chronic pain. The report noted limited data and study quality. It did not assess dabs.

What Equipment Do You Need for Dabs

Pain is a symptom, not one condition. Response varies by cause, dose, and route. Dabs deliver THC fast. That speed raises the chance of anxiety, impaired coordination, and tolerance.

Risks

• Dependence: About 3 in 10 people who use cannabis develop cannabis use disorder. Risk is higher for people who start before age 18.
• Lung injury: Vaping concentrates can cause respiratory symptoms. Contaminated products have caused lung injury outbreaks.
• THC dose: Dabs raise tolerance. Withdrawal can include irritability and sleep problems.
• Driving: THC impairs coordination for hours after use.

If a person uses dabs for pain

Start with a low dose. A 2 mg to 5 mg THC dose is common for edible products. Inhaled doses act within minutes. Wait 15 minutes before a second dose. Keep products labeled. Store them away from children and pets. Tell a clinician about use, including dose and frequency.

Clinical context

Some cannabinoid drugs have approval for specific conditions. The FDA approved Epidiolex (CBD) for certain seizures. The FDA has not approved cannabis for pain. The CDC reports that cannabis use can lead to dependence. The NIH calls for more research on cannabinoids and pain.